![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 1033-1041, March 2003
Department of Pharmacology, Emory University School of Medicine,
Atlanta, Georgia
Rats were trained to discriminate 4-h pretreatment with 10 mg/kg morphine and 15-min pretreatment with 0.3 mg/kg naltrexone (morphine
naltrexone) from pretreatment with saline and 0.3 mg/kg naltrexone (saline
naltrexone). The discrimination seems to derive from interoceptive stimuli from antagonist-precipitated withdrawal from
acute morphine dependence. The purpose of this study was to extend
pharmacological characterization of the discrimination by testing
opioid agonists other than morphine and antagonists other than
naltrexone. Of seven µ-opioid agonists tested in place of morphine,
only two (heroin and levorphanol) substituted completely for it; trials
completed on the morphine
naltrexone-appropriate lever increased as a function of agonist and naltrexone dose. Agonists
with intrinsic efficacy higher (etorphine, fentanyl, and methadone) or
lower (buprenorphine and meperidine) than that of morphine substituted
only partially. However, when naltrexone was administered during
continuous infusion of fentanyl or methadone via s.c. osmotic pump,
rats responded as if they had received morphine
naltrexone;
discriminative responding correlated with global withdrawal scores.
Rats responded primarily on the saline
naltrexone-appropriate lever
when naltrexone was administered after pretreatment with dextrorphan,
the dextrorotatory isomer of levorphanol, or
-opioid agonists
(5-
,7-
,8-
)-(+)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl]-benzeneacetamide (U69,593) and spiradoline. Antagonists with no intrinsic efficacy at
µ-opioid receptors (naloxone and diprenorphine) substituted completely for naltrexone, whereas those with some efficacy (nalorphine and levallorphan) substituted partially. Thus,
morphine
naltrexone-like stimulus control of behavior by drugs
administered acutely requires pretreatment with certain µ-opioid
agonists and a pure antagonist, is independent of agonist efficacy, and
is stereoselective. Interoceptive stimuli from naltrexone-precipitated
opioid withdrawal are more similar across morphine-like agonists during
chronic dependence than they are during acute dependence.
This article has been cited by other articles:
![]() |
D. A. White and S. G. Holtzman Discriminative Stimulus Effects of Acute Morphine Followed by Naltrexone in the Squirrel Monkey: A Further Characterization J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 374 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Walker, M. J. Picker, A. Granger, and L. A. Dykstra Effects of Opioids in Morphine-Treated Pigeons Trained to Discriminate among Morphine, the Low-Efficacy Agonist Nalbuphine, and Saline J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 150 - 158. [Abstract] [Full Text] [PDF] |
||||